The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

Novo Nordisk is introducing a direct-to-patient delivery option for its flagship weight loss drug Wegovy (semaglutide), ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Zepbound, a brand-name version of tirzepatide, is part of a class of medications called glucagon-like peptide 1 (GLP-1) agonists. In 2023, the Food and Drug Administration approved it for weight ...

Avacta Therapeutics to sell Launch Diagnostics to Duomed Belgium NV for £12.9 million in cash: London Monday, March 10, 2025, 12:00 Hrs [IST] Avacta Therapeutics, a life sciences ...

US taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, ...